Toyonaka, Japan

Takayuki Kanazawa



 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Takayuki Kanazawa: Innovator in Cancer Treatment

Introduction

Takayuki Kanazawa is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 2 patents, Kanazawa is recognized for his work in creating pharmaceutical compositions that target cancer cells.

Latest Patents

Kanazawa's latest patents include a method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells. This invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8. Another significant patent is a method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8. This also offers a pharmaceutical composition for cancer treatment that includes an antibody against CCR8.

Career Highlights

Throughout his career, Kanazawa has worked with prominent organizations such as Shionogi & Company Limited and Osaka University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Some of his notable coworkers include Tetsuya Yoshida and Yujiro Kidani. Their collaboration has likely played a role in the development of his innovative patents.

Conclusion

Takayuki Kanazawa's work in cancer treatment exemplifies the impact of innovation in medicine. His patents reflect a commitment to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…